|Videos|June 14, 2021

Look beyond IOP in treating glaucoma patients

Author(s)Benjamin P. Casella, OD, FAAO, John Berdahl, MD

How Equinox’s new goggles might help to treat glaucoma

It’s more than intraocular pressure, says John Berdahl, MD, founder and CMO of Equinox. Glaucoma is a multipressure disease, so consider intracranial pressure as well. He discusses this concept with Ben Casella, OD, FAAO, chief optometric editor of Optometry Times®, and explains how Equinox’s new goggles might help to treat glaucoma.

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Look beyond IOP in treating glaucoma patients

Related Content

NEI-backed ANDI tool guides ODs in amblyopia management

Practical tips and tricks: Kerataconus treatment advice for peers

Study takeaways: What new research on retinal cell communication means for eye care

Hybrid AI model distinguishes keratoconus from healthy eyes with 90% accuracy

Balance Ophthalmics receives FDA 510(k) clearance for wireless-enabled nocturnal IOP device

Latest CME

(CME Credit) Navigating Pharmacological Presbyopia Treatment for Enhanced Patient Care

Neurotrophic Keratitis Insights: An Interactive Corneal Sensitivity Testing Workshop

(COPE Credit) Navigating Pharmacological Presbyopia Treatment for Enhanced Patient Care

(COPE Track) Small Mites, Big Impact: Revolutionizing Demodex Blepharitis Care

(CME Track) Small Mites, Big Impact: Revolutionizing Demodex Blepharitis Care

Retina Updates in Montréal

PER Global Perspectives: The TROP2-Targeted ADC Landscape in NSCLC and How to Interpret the Evidence

Interventional Dry Eye: A Stepwise Treatment & Management Approach

Rapid Reviews in Retina™: Emerging Updates from Spring 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

(CME Track) Rapid Reviews in Retina™: Emerging Updates from Summer 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

(CME Track) A Forward Look at Anti-VEGF Therapies: A Paradigm Shift in Neovascular Retinal Disease Management

(CME Track) The Evolution of MacTel Management: Integrating Neuroprotective Therapies Into Clinical Practice

(CME Track) Collaborating Across the Continuum™: Best Practices in Patient-Centric Team Management of XLRP

(CME Track) Community Collaborative Connections™: Optimizing the Collaborative Care of Neovascular Retinal Disease in a New Age of Treatment

Navigating Advances in Neovascular Retinal Disease: Translating Evidence to Practice in AMD, DME, and RVO

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

(COPE Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Navigating Ocular Toxicities: A Multidisciplinary Roadmap for Managing Adverse Events in Targeted Cancer Therapy

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

Study finds no link between semaglutide and a blinding form of macular degeneration

Euclid Vision receives FDA clearance for Be Free Day toric contact lenses

Five pillars of a strong OD/MD partnership

Oculis enrolls first patient in licaminlimab PREDICT-1 DED trial

Eye drops used to slow childhood nearsightedness affect vision differently by dose, review finds